View Clinical Trial (Medical Research Study)
Behavioral Exercise Intervention for Smoking Cessation - NCT00713063-02906(Clinical Trial 230517)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Providence |
|
State:
|
|
RI |
| Zip Code: |
|
02906 |
| Conditions: |
|
Nicotine Dependence |
| Purpose: |
|
The purpose of this study is to test the effect of a moderate-intensity aerobic exercise
intervention for smokers interested in quitting smoking. We expect that this project will
contribute much needed knowledge about the role of aerobic exercise in smoking cessation.
If the efficacy of moderate-intensity, aerobic exercise for smoking can be established,
smokers may have a valuable adjunct to more traditional smoking cessation approaches.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
1. are between 18 and 65 years of age
2. are current smokers (i.e., smoking at least 10 cigarettes per day)
3. are sedentary, i.e., have not participated regularly in aerobic physical exercise
(for at least 20 minutes per day, 3 days per week) for the past six months.
Exclusion Criteria:
1. current DSM-IV Axis I psychiatric disorder as assessed by SCID-NP
2. Substance abuse or dependence (excluding nicotine dependence) within the past 6
months
3. lifetime DSM-IV diagnosis of a bipolar disorder as assessed by the SCID-NP
4. lifetime history of a psychotic disorder or current psychotic symptoms as assessed by
the SCID-NP
5. current suicidality or homicidality
6. marked organic impairment
7. physical disabilities or medical problems (such as a history of diabetes,
hypertension, seizure disorder, coronary heart disease, valvular heart disease, and
pulmonary disease) or use of medications (such as beta blockers) that would prevent
or hinder participation in a program of moderate intensity exercise
8. current pregnancy of intent to become pregnant during the next 12 weeks, and i)
current use of any pharmacotherapy, including transdermal nicotine replacement, for
smoking cessation |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
November 11, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|